Johnson & Johnson reported $7.42B in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US USD 2.17B 316M
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 3.09B 52M
Baxter International BAX:US USD 547M 2M
Becton, Dickinson and BDX:US USD 926.97M 25.03M
Biogen BIIB:US USD 821M 53.8M
Boston Scientific BSX:US USD 745M 26M
Cardiovascular Systems CSII:US USD -10650000 1.01M
Dexcom DXCM:US USD 159.5M 59.3M
Eli Lilly And LLY:US USD 2.04B 38.3M
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Globus Medical GMED:US USD 65.14M 8.85M
Insulet PODD:US USD -5700000 30.4M
Integra Lifesciences IART:US USD 101.31M 2.64M
Johnson & Johnson JNJ:US USD 7.42B 655M
Medtronic MDT:US USD 3.73B 2B
Merk MRK:US USD 4.89B 560M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 7.38B 3.3B
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 12.11B 2.43B
Sanofi SAN:FP EUR 4.43B 1.77B
Tandem Diabetes Care TNDM:US USD -15734000 2.78M
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
Zimmer Biomet Holdings Inc ZBH:US USD 476.7M 78.5M